Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals recorded 5 insider transactions totaling $514,889.42 across 2 transaction types. Tax payments accounted for 4 of 5 transactions and $436,067.04 of total value; the lone sale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results